RecruitingNCT03023371

National Registry of IgG4-RD in China


Sponsor

Peking Union Medical College Hospital

Enrollment

900 participants

Start Date

Dec 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to establish a nation-wide cohort study of IgG4-related disease (IgG4-RD) in China. Methods: All the patients fulfilling diagnostic criteria of IgG4-RD (2011) would be enrolled from multi-centers around China. A online database system has been established. Endpoints: The primary endpoint is to investigate the clinical manifestations of Chinese IgG4-RD patients; the secondary endpoints including the demographic features,laboratory characteristics, immunological tests, imaging and pathological features, in addition, the treatment and prognosis of the disease.


Eligibility

Inclusion Criteria1

  • Conforming to the diagnostic criteria of IgG4-RD (2011);

Exclusion Criteria1

  • Excluding other mimicing IgG4-RD, including tumors, vasculitis and sarcoidosis.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03023371


Related Trials